Small bowl of soft oatmeal with a light peanut butter swirl on matte grey stone

shot-day · breakfast · 10 min

Oatmeal + peanut butter shot-day breakfast

Small bowl of soft oats with a measured peanut-butter swirl and protein powder — gentle volume, solid grams.

Editorially reviewed · Last updated July 2026 · How we review

1

makes 1 serving

28 g protein4 g fiber320 kcalper serving

Ingredients

  • 30 gRolled oatsabout ⅓ cup dry — keep the bowl small
  • 180 mlWater or unsweetened almond milk
  • 0.5 scoopWhey protein isolatestirred in off heat
  • 1 tbspPeanut buttermeasured; not a heaping spoon
  • 1 pinchCinnamon (optional)
  • 0.3Banana (optional)few slices only

Steps

  1. Cook a small oat base

    Simmer oats in water or almond milk until soft and loose — more porridge than paste. Under-cook rather than gluey.

  2. Cool slightly, add whey

    Take off heat for a minute so the whey does not seize. Stir half a scoop until smooth. Thin with a splash of liquid if needed.

  3. Peanut butter swirl

    Measure one tablespoon of peanut butter and swirl it through. Do not add a second spoon “for flavour.”

  4. Eat warm, slowly

    Optional cinnamon or two banana slices. Stop at comfortable fullness; leftover oats can reheat later the same day.

When you can barely eat

Skip the peanut butter and banana. Make 20 g oats very thin (extra liquid), stir in half a scoop of whey, and sip-spoon like a warm shake. Roughly 18–20 g protein with less fat and less volume.

~19 g protein on this smaller version

  • 20 g Rolled oats
  • 200 ml Water
  • 0.5 scoop Whey protein isolate

Notes

  • Oats + PB is a common community shot-day breakfast when cold dairy is unappealing.
  • If fiber is hard during escalation weeks, cut oats to 20 g and keep the whey.
  • No dose milligrams — phase language only.

Prints the amounts and nutrition for your current serving count (1).

How we keep this honest
What this is
Educational information, not medical advice. It reports published research — it doesn’t recommend that you use, obtain, or supply anything.
Regulatory status
Retatrutide and similar peptides are investigational — not approved by the FDA or any regulator. Semaglutide and tirzepatide are prescription-only medicines, available only through a licensed prescriber.
Our standard
Every claim traces to a primary source. We label the strength of evidence and flag estimates as estimates — never as clinical fact.
No commercial ties
We don’t sell, supply, or link to suppliers of any medicine, and aren’t affiliated with any manufacturer.

Do not make decisions about your health without consulting a qualified healthcare provider. For trial enrolment, see ClinicalTrials.gov. More on how we review.